Halide ion effects on human Ether-à-go-go related gene potassium channel properties

Assay Drug Dev Technol. 2013 Nov-Dec;11(9-10):544-50. doi: 10.1089/adt.2013.531. Epub 2013 Oct 22.

Abstract

The human Ether-à-go-go related gene (hERG) potassium channel has been widely used to counter screen potential pharmaceuticals as a biomarker to predict clinical QT prolongation. Thus, higher throughput assays of hERG are valuable for early in vitro screening of drug candidates to minimize failure in later-stage drug development due to this potentially adverse cardiac risk. We have developed a novel method utilizing potassium fluoride to improve throughput of hERG counter screening with an automated patch clamp system, PatchXpress 7000A. In that method, ∼50% substitution of internal Cl(-) with F(-) greatly increases success rate without substantially altering the biophysical properties of the hERG channel or compromising data quality. However, effect of F(-) or other halide ions on hERG channel properties has not been studied in detail. In this study, we examined effects of complete replacement of Cl(-) in internal solution with halide ions, F(-), or Br(-). We found that (1) F(-) slightly shifts the voltage dependence of hERG channel activation to more positive voltages, while Br(-) shifts it to more negative voltages; (2) Br(-) shifts to more positive voltages both the inactivation-voltage relationship and the peak position of channel full activation of hERG; (3) F(-) slows hERG activation, while both F(-) and Br(-) make the channel close faster; (4) neither F(-) nor Br(-) have any effect on hERG inactivation kinetics. In conclusion, compared to Cl(-), F(-) has subtle effect on hERG activation, while Br(-) has distinct effects on certain, but not all biophysical properties of hERG channel.

MeSH terms

  • Animals
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Drug Evaluation, Preclinical / methods
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels / antagonists & inhibitors*
  • Ether-A-Go-Go Potassium Channels / physiology*
  • Flow Cytometry / methods
  • Flow Injection Analysis / methods
  • Halogens / pharmacology*
  • Ion Channel Gating / drug effects
  • Ion Channel Gating / physiology*
  • Ions
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology*
  • Patch-Clamp Techniques / methods*
  • Potassium Channel Blockers / pharmacology*

Substances

  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Halogens
  • Ions
  • KCNH2 protein, human
  • Potassium Channel Blockers